2-(dipropylamino)-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid
C23H30F3N3O6S — CID 146054482
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(dipropylamino)-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid
2-(dipropylamino)-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid (PubChem CID 146054482) has the molecular formula C23H30F3N3O6S and a molecular weight of 533.57 g/mol. Its IUPAC name is 2-(dipropylamino)-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 2-(dipropylamino)-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 146054482 |
| Molecular Formula | C23H30F3N3O6S |
| Molecular Weight | 533.57 g/mol |
| Exact Mass | 533.18 |
| IUPAC Name | 2-(dipropylamino)-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridine-3-carboxylic acid;2,2,2-trifluoroacetic acid |
| SMILES | CCCN(CCC)c1ncc(NS(=O)(=O)c2ccc(C(C)C)cc2)cc1C(=O)O.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C21H29N3O4S.C2HF3O2/c1-5-11-24(12-6-2)20-19(21(25)26)13-17(14-22-20)23-29(27,28)18-9-7-16(8-10-18)15(3)4;3-2(4,5)1(6)7/h7-10,13-15,23H,5-6,11-12H2,1-4H3,(H,25,26);(H,6,7) |
| InChIKey | POTOGLZXJIKVRV-UHFFFAOYSA-N |
| XLogP | 4.96 |
| TPSA | 136.90 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 533.57 |
| LogP ≤ 5 | 4.96 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146054482 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.